Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release.
Chitosan is a cationic polymer of natural origin and has been widely explored as a pharmaceutical excipient for a broad range of biomedical applications. While generally considered safe and biocompatible, chitosan has the ability to induce inflammatory reactions, which varies with the physical and c...
Guardado en:
Autores principales: | Gaurav Bajaj, William G Van Alstine, Yoon Yeo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/26c4d74d27eb411083e2cd262dceef08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bottom-up fabrication of zwitterionic polymer brushes on intraocular lens for improved biocompatibility
por: Han Y, et al.
Publicado: (2016) -
Development of a biocompatible polymeric chitosan system for the release of compounds with leishmanicidal activity
por: Jorge Higuita-Castro, et al.
Publicado: (2021) - Journal of excipients and food chemicals
-
Particle Engineering of Chitosan and Kaolin Composite as a Novel Tablet Excipient by Nanoparticles Formation and Co-Processing
por: Chonwipa Yarangsee, et al.
Publicado: (2021) -
Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients
por: Savannah J. McFeely, et al.
Publicado: (2021)